Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concomitant levofloxacin therapy vs sequential levofloxacin therapy for Helicobacter pylori eradication
2010-024644-15Phase 3Active
- Sponsor
- Azienda Ospedaliera Universitaria Luigi Vanvitelli
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of levofloxacin in Helicobacter pylori infection (2 arms), sponsored by Azienda Ospedaliera Universitaria Luigi Vanvitelli. Primary endpoint: H. pylori eradication rate. Started Mar 2012; status: active.
02
Drugs
levofloxacin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on 2010-024644-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-024644-15.